COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with COPD based on their smoking history or exposure to other risk factors, confirmed by a specific breathing test result (post-bronchodilator FEV1/FVC ratio below 0.7)
- People whose blood oxygen level at rest while breathing room air is above 60 mmHg, confirmed by a blood test taken within the past week
- People whose COPD is currently stable and being treated according to the latest recommended medical guidelines (GOLD guidelines)
- People who are willing and able to provide written, signed consent before entering the study
Who may not be able to join:
- People who have had a chest infection or a worsening of their COPD symptoms, a hospital stay, or a change in medication in the past 3 months
- People whose COPD medications have changed in the past month
- People with a history of asthma or airways that respond and open up significantly after using a reliever inhaler (confirm with trial site)
- People with high blood pressure in the lungs (pulmonary hypertension)
- People with heart failure, specifically where the heart's pumping function is below 50% on a recent heart ultrasound
- People with severe circulation problems in the legs or arms (severe peripheral artery disease)
- People with significant kidney disease where kidney function has fallen to a low level (eGFR below 30 ml/min)
- People with an active infection, whether short-term or long-term
- People currently being treated for cancer or a blood disorder
- People with a history of a condition affecting the nerves or muscles (neuromuscular disorder)
- People with a history of severe intellectual disability or serious mental health disorder
- People for whom moderate to vigorous exercise or exercise testing would not be considered safe, including those who have had a heart attack in the past 6 months, have unstable chest pain, have experienced fainting, have severe uncontrolled heart valve problems, uncontrolled irregular heartbeat, recent blood clots in the lungs or legs, a suspected tear in a major blood vessel, fluid on the lungs, severely uncontrolled high blood pressure at rest, or physical conditions that prevent safe exercise performance
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Differences between MICE and HIIE protocol in brain HbO2 (changes from the baseline) during rest; Differences between MICE and HIIE protocol in brain HbO2 (changes from the baseline) during exercise; Differences between MICE and HIIE protocol in brain HbO2 (changes from the baseline) during recovery; Differences between MICE and HIIE protocol in brain HHb (changes from the baseline) during rest; Differences between MICE and HIIE protocol in brain HHb (changes from the baseline) during exercise; Differences between MICE and HIIE protocol in brain HHb (changes from the baseline) during recovery;...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.